Top Stories
-
The way SARS-CoV-2 mutates in immunocompromised patients to escape Paxlovid could help chemists design better drugs that are more difficult for the virus to sidestep.
Topic
-
Columbia researchers have found why babies are susceptible to repeated bouts of common respiratory infections—but also have a unique weapon to fight off new pathogens that healthy adults lack.
Topic
-
Columbia University experts explain the mosquito-borne illness and its treatments.
Topic
-
Patients with mpox who were treated with the antiviral drug tecovirimat had similar outcomes regardless of HIV status, find researchers at Columbia University and Weill Cornell Medicine.
Topic
Latest News
- May 2, 2023
At the award ceremony, the nation's top infectious disease expert spoke about his decades-long effort to end the HIV/AIDS crisis (see video in the article).
Topic
- April 10, 2023
Brain development is normal in babies whose moms had mild COVID during pregnancy, a study by Columbia University researchers has found.
Topic
- January 12, 2023
Columbia researchers are working with the MTA on a project aimed at strengthening the resilience of public transit during public health disasters.
Topic
- December 1, 2022
Obstacles remain before the world reaches the point of eliminating AIDS, but new prevention technologies and outreach programs are reasons to be optimistic about the future.
Topic
- November 21, 2022
The diminished power of the immune system in older adults is usually blamed on the aging process. A new study shows that decades of inhaled particulates due to air pollution also take a toll.
Topic
- November 18, 2022
Initial reports of the bivalent booster’s effectiveness have created confusion among the public. David Ho discusses his own results, the bottom line, and what to expect from COVID this winter.
Topic
- November 10, 2022
Cases of COVID, influenza, and RSV are surging in children and adults, along with a slew of other infectious diseases that went under the radar during the first two years of the pandemic.
Topic
- October 31, 2022
Quick fixes are not the answer when seeking ways to boost your immunity or increase your protection against infection.
Topic
- September 13, 2022
Columbia physicians explain why long COVID is still a “thing” and what we need to know to better identify and treat patients with the syndrome.
Topic
- September 6, 2022
An infectious diseases expert explains why the new boosters target the omicron variant and who should get one.
Topic
